Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Roche
Company Monitoring Page for Roche
latest headlines for company on cafepharma
Hits, but mostly misses for Roche’s 4 late-stage trials of GI drug hopeful etrolizumab
Fierce Biotech
Mon, 08/10/20 - 10:53 am
Tags:
Roche
,
Genentech
,
etrolizumab
,
clinical trials
,
ulcerative colitis
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
Xconomy
Sat, 08/8/20 - 10:56 pm
Tags:
Roche
,
risdiplam
,
SMA
,
spinal muscular atrophy
,
FDA
In surprising setback, combo of Roche’s Tecentriq and chemo fails to help patients with triple-negative breast cancer
Endpoints
Fri, 08/7/20 - 10:56 am
Tags:
Roche
,
FDA
,
triple negative breast cancer
,
Tecentriq
Dicerna guides Roche-partnered hepatitis B drug past early test
Fierce Biotech
Thu, 08/6/20 - 10:15 am
Tags:
Roche
,
Dicerna Pharmaceuticals
,
hepatitis B
,
RG6346
,
clinical trials
FDA approves Roche’s Tecentriq plus Cotellic and Zelboraf for people with advanced melanoma
Pharmaceutical Business Review
Mon, 08/3/20 - 10:33 am
Tags:
Roche
,
FDA
,
Tecentriq
,
Cotellic
,
Zelboraf
,
melanoma
Roche’s Tecentriq claims melanoma OK, but don’t expect a sales surge
Pharmaforum
Fri, 07/31/20 - 10:43 am
Tags:
Roche
,
Tecentriq
,
FDA
,
melanoma
,
Bristol-Myers Squibb
,
Merck
Roche’s tocilizumab fails to achieve primary endpoints for Covid-19-related pneumonia
Pharmaceutical Business Review
Thu, 07/30/20 - 10:59 am
Tags:
Roche
,
Actemra
,
RoActemra
,
COVID-19
,
clinical trials
,
COVID-19 pneumonia
Roche doubles down on Tau
EP Vantage
Wed, 07/29/20 - 12:20 pm
Tags:
Roche
,
anti-tau antibodies
,
UCB Pharma
,
UCB01017
,
Alzheimer's disease
Go or no go? Valuable drugs set for FDA decisions
EP Vantage
Wed, 07/29/20 - 10:54 am
Tags:
FDA
,
drug approvals
,
Novartis
,
inclisiran
,
Biomarin
,
valrox
,
Roche
,
risdiplam
,
GSK
,
belantamab mafodotin
,
Gilead Sciences
,
Galapagos
,
filgotinib
Roche drops hep B antiviral as late-stage pipeline tests 'largely on track' despite COVID-19 disruption
Fierce Biotech
Thu, 07/23/20 - 11:12 am
Tags:
Roche
,
antiviral
,
hepatitis B
,
RG6217
Roche, Jnana sign multi-target collaboration deal for small molecule drugs
Pharmaceutical Business Review
Thu, 07/23/20 - 10:58 am
Tags:
Roche
,
Jnana Therapeutics
,
small molecule drugs
Roche suffers double whammy as biosimilars, COVID-19 joined hands in weak quarter
Fierce Pharma
Thu, 07/23/20 - 10:54 am
Tags:
Roche
,
earnings
10 drugmakers expected to make the most money in the next 5 years
Beckers Hospital Review
Wed, 07/22/20 - 12:07 am
Tags:
Roche
,
pharma industry
,
drug sales
10 most valuable R&D projects in the pharmaceutical industry pipeline
Beckers Hospital Review
Mon, 07/20/20 - 11:49 pm
Tags:
R&D
,
drug development
,
Eli Lilly
,
Novartis
,
Argenx
,
Bristol-Myers Squibb
,
Vir Biotechnolgy
,
Biogen
,
GSK
,
Iovance
,
Roche
Roche, PicnicHealth start RWD partnership with multiple sclerosis focus
MedCity News
Mon, 07/20/20 - 10:32 am
Tags:
Roche
,
PicnicHealth
,
MS
,
multiple sclerosis
,
RWD
,
real world data
,
artificial intelligence
Alzheimer’s catalysts round off a year dominated by Biogen
EP Vantage
Fri, 07/17/20 - 11:17 am
Tags:
Alzheimer's disease
,
Roche
,
Eli Lilly
,
AC Immune
,
Biohaven
,
Cortexyme
,
Biogen
Roche, Blueprint Medicines sign $1.7bn worth deal for pralsetinib
Pharmaceutical Business Review
Tue, 07/14/20 - 10:29 am
Tags:
Roche
,
Blueprint Medicines
,
pralsetinib
,
RET-altered cancer
Genentech's Tecentriq-Avastin Combo Fails to Hit Primary Endpoint in Ovarian Cancer
BioSpace
Mon, 07/13/20 - 12:15 pm
Tags:
Genentech
,
Roche
,
clinical trials
,
Tecentriq
,
ovarian cancer
Roche targets 2021 start for hemophilia A gene therapy phase 3 as optimization effort drags on
Fierce Biotech
Mon, 07/13/20 - 11:11 am
Tags:
Roche
,
hemophilia A
,
Spark Therapeutics
,
SPK-8011
FDA bars the door — for now — against Merck’s star cancer drug after Roche beat them to the punch
Endpoints
Wed, 07/8/20 - 10:43 am
Tags:
Merck
,
FDA
,
complete response letter
,
Keytruda
,
Eisaid
,
Lenvima
,
hepatocellular carcinoma
,
Roche
Pages
« first
‹ previous
…
26
27
28
29
30
31
32
33
34
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
a dog would most likely chase a: cat, rock, house
*
Fill in the blank.